Improving Blood Pressure in Colorado
1 other identifier
interventional
290
1 country
3
Brief Summary
We will improve hypertension control in Colorado by implementing a population-based intervention using interactive voice response (IVR) technology that will be delivered to patients in three healthcare systems across Colorado (Denver Health and Hospitals \[DH\], VA Colorado Healthcare System \[VA\], and Kaiser Permanente of Colorado \[KPCO\]). Together, these organizations serve over 1 million Coloradans. The IVR-based hypertension program will: 1) reach out to more patients using fewer resources than a traditional patient visit approach, 2) implement evidence based guidelines for therapy, 3) facilitate patients' acquisition of medications by allowing them to order and receive medications at home, and 4) enhance medication adherence using tailored educational and motivational messages. HYPOTHESES:
- 1.A sizable population of patients is at high risk for further cardiovascular morbidity and mortality, based on uncontrolled hypertension.
- 2.An IVR-centered intervention among patients with diagnosed but uncontrolled hypertension is feasible.
- 3.An IVR-centered intervention plus usual care for these patients improves BP control, compared to usual care alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Mar 2006
Longer than P75 for not_applicable hypertension
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 23, 2007
CompletedFirst Posted
Study publicly available on registry
August 27, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedApril 27, 2012
April 1, 2012
5.5 years
August 23, 2007
April 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
We will assess the primary measures of effectiveness (control of blood pressure) in the clinic at baseline and 6 months, for both the usual care plus IVR arm and usual care arm alone.
6 months of follow-up
Study Arms (2)
1
EXPERIMENTALUsual care plus use of Interactive Voice Recognition system
2
NO INTERVENTIONUsual care
Interventions
Use of telephone-based Interactive Voice Recognition system, for reporting of health information and blood pressure measurements
Eligibility Criteria
You may qualify if:
- years of age or older
- have diagnosed but uncontrolled hypertension
- Most recent measurement and one other measurement of the 3 most recent blood pressure measurements in the past 2 years have a systolic pressure \>140mmHg or a diastolic pressure \>90mmHg. For patients with a diagnosis of diabetes or chronic kidney disease the blood pressure cut-offs will be systolic \>130 mm Hg or a diastolic pressure \> 80 mm Hg
- not on organizational "do not call" lists or deceased lists
- have been approved for invitation into the study by their physician
- do not have a life-threatening illness
- are not on more than 4 antihypertensive medications
- can use a telephone
- speak either English or Spanish
You may not qualify if:
- on organizational "Do Not Call" list or deceased list
- physician does not give permission for them to be included in the study
- younger than 18 years of age
- has a life-threatening illness
- currently takes more than 4 anti-hypertension medications
- does not have or cannot use a phone
- does not speak English or Spanish (languages available in IVR)
- does not want to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- US Department of Veterans Affairscollaborator
- Denver Health Medical Centercollaborator
- Colorado Health Outcomes Programcollaborator
Study Sites (3)
Denver Health Medical Center
Denver, Colorado, United States
Denver VA Medical Center
Denver, Colorado, United States
Kaiser Permanente Colorado
Metro Denver Area, Colorado, United States
Related Publications (1)
Welch LK, Olson KL, Snow KE, Pointer L, Lambert-Kerzner A, Havranek EP, Magid DJ, Ho PM. Systolic blood pressure control after participation in a hypertension intervention study. Am J Manag Care. 2011;17(7):473-8.
PMID: 21819167DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Ho, MD PhD
Denver VA Medical Center
- PRINCIPAL INVESTIGATOR
Edward Havranek, MD
Denver Health Medical Center
- PRINCIPAL INVESTIGATOR
David Magid, MD MPH
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2007
First Posted
August 27, 2007
Study Start
March 1, 2006
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
April 27, 2012
Record last verified: 2012-04